PEPGEN INC. Earnings Per Share (Basic)
PEPGEN INC. (PEPG) reported Earnings Per Share (Basic) of -$0.26 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- PEPGEN INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.26.
- PEPGEN INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.26.
- PEPGEN INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.27.
- PEPGEN INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.52.
- PEPGEN INC. earnings per share, basic for fiscal 2025 was -$2.12.
- PEPGEN INC. earnings per share, basic for fiscal 2024 was -$2.85.
- PEPGEN INC. earnings per share, basic for fiscal 2023 was -$3.30.
- PEPGEN INC. earnings per share, basic for fiscal 2022 was -$4.42.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.26 10-Q · filed 2026-08-06 | -$0.51 10-Q · filed 2026-08-06 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.19 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | -$0.26 10-Q · filed 2026-05-12 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.94 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.50 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$0.70 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$1.31 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.12 10-K · filed 2026-03-04 |
| 2025-09-30 | -$0.52 10-Q · filed 2025-11-12 | -$1.23 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.14 10-Q · filed 2025-11-12 | -$2.83 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | -$0.70 10-Q · filed 2026-08-06 | -$1.63 10-Q · filed 2026-08-06 | -$2.31 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.97 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$0.92 10-Q · filed 2026-05-12 | -$1.61 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.26 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.14 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2024-12-31 | -$0.68 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$1.34 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$2.21 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$2.85 10-K · filed 2026-03-04 |
| 2024-09-30 | -$0.66 10-Q · filed 2025-11-12 | -$1.53 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$2.17 10-Q · filed 2025-11-12 | -$2.97 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2024-06-30 | -$0.87 10-Q · filed 2025-08-07 | -$1.52 10-Q · filed 2025-08-07 | -$2.33 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$3.28 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2024-03-31 | -$0.63 10-Q · filed 2025-05-08 | -$1.43 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$2.39 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$3.21 derived: net income ÷ weighted average shares · filed 2025-11-12 |
| 2023-12-31 | -$0.82 derived: net income ÷ weighted average shares · filed 2025-02-24 | -$1.80 derived: net income ÷ weighted average shares · filed 2025-02-24 | -$2.62 derived: net income ÷ weighted average shares · filed 2025-02-24 | -$3.30 10-K · filed 2025-02-24 |
| 2023-09-30 | -$0.98 10-Q · filed 2024-11-07 | -$1.80 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.49 10-Q · filed 2024-11-07 | -$3.12 derived: net income ÷ weighted average shares · filed 2024-11-07 |
| 2023-06-30 | -$0.82 10-Q · filed 2024-08-08 | -$1.51 10-Q · filed 2024-08-08 | -$2.14 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.93 derived: net income ÷ weighted average shares · filed 2024-11-07 |
| 2023-03-31 | -$0.69 10-Q · filed 2024-05-14 | -$1.32 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.11 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$3.16 derived: net income ÷ weighted average shares · filed 2024-11-07 |
| 2022-12-31 | -$0.63 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$1.42 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$2.49 derived: net income ÷ weighted average shares · filed 2024-03-29 | -$4.42 10-K/A · filed 2024-03-29 |
| 2022-09-30 | -$0.79 10-Q · filed 2023-11-08 | -$1.91 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$4.18 10-Q · filed 2023-11-08 | -$6.20 derived: net income ÷ weighted average shares · filed 2023-11-08 |
| 2022-06-30 | -$1.23 10-Q · filed 2023-08-08 | -$4.70 10-Q · filed 2023-08-08 | -$8.02 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$12.05 derived: net income ÷ weighted average shares · filed 2023-11-08 |
| 2022-03-31 | -$18.94 10-Q · filed 2023-05-11 | -$26.93 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$36.15 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$42.34 derived: net income ÷ weighted average shares · filed 2023-11-08 |
| 2021-12-31 | -$7.75 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$16.80 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$22.85 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$30.27 10-K · filed 2023-03-23 |
| 2021-09-30 | -$9.07 10-Q · filed 2022-11-10 | -$15.10 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$22.52 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$6.03 10-Q · filed 2022-08-12 | -$13.45 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |